Skip to content

Evommune EVMN Operating Income

Operating Income at other companies

Evommune
 logo
Evommune EVMN
-$682.81K-2,027%
CHE
ChemedCHE
$84.58M-10.7%
RBC Bearings logo
RBC BearingsRBC
$119.1M+18.3%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$117.42M+20.0%
SBA Communications logo
SBA CommunicationsSBAC
$342.85M+2.4%
CSX logo
CSXCSX
$1.25B+20.4%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's operating income?
Evommune (EVMN) reported operating income of -$682.81K in Q1 2026.
How has Evommune 's operating income changed year-over-year?
Evommune 's operating income decreased by 2027.1% year-over-year, from -$32.1K to -$682.81K.
What does operating income mean?
Reflects the profit or loss generated from core business operations after subtracting operating expenses from gross profit. It is a key indicator of the company's ability to sustain its operations through its primary business activities without relying on non-operating income.